Index of reports
> Death (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viramune (Nevirapine) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Viramune side effects in 41 year old male
Reported by a physician from United Kingdom on 2012-06-05
Patient: 41 year old male, weighing 62.5 kg (137.5 pounds)
Reactions: Rash Generalised, Vomiting, Swelling Face, Mouth Ulceration, Tachycardia, Pyrexia, Plantar Fasciitis, Diarrhoea, Paraneoplastic Pemphigus, Abdominal Distension, Treponema Test Positive, Lymphoma, Stevens-Johnson Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Viramune
Other drugs received by patient: Antobiotics; Lots OF Medications
Possible Viramune side effects in female
Reported by a physician from France on 2012-04-30
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1tab per day
Administration route: Oral
Indication: HIV Infection
Viramune
Dosage: 200mg twice per day
Administration route: Oral
Indication: HIV Infection
Ramipril
Dosage: 1tab per day
Administration route: Oral
Indication: Hypertension
Possible Viramune side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-19
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Viramune
Dosage: 400 mg
Administration route: Oral
Indication: HIV Infection
Cotriatec
Administration route: Oral
Indication: HIV Infection
Abacavir Sulfate / Lamivudine
Dosage: 600/300mg
Administration route: Oral
Indication: HIV Infection
Possible Viramune side effects in male
Reported by a physician from India on 2012-03-27
Patient: male, weighing 49.5 kg (108.9 pounds)
Reactions: Multi-Organ Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Viramune
Dosage: 400 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-06
End date: 2012-02-28
Zidovudine
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-05
End date: 2012-02-28
Other drugs received by patient: Disodium Hydrogen Citrate; Lamivudine + Zidovudine; Efavirenz; Tenofovir Disoproxil Fumarate; Norfloxacin; Omeprazole; Oral Rehydration Solution; Lamivudine + Zidovudine; Domperidone
Possible Viramune side effects in male
Reported by a physician from India on 2012-03-20
Patient: male, weighing 49.5 kg (108.9 pounds)
Reactions: Multi-Organ Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Zidovudine
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-05
End date: 2012-02-28
Viramune
Dosage: 400 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-06
End date: 2012-02-28
Other drugs received by patient: Norfloxacin; Lamivudine + Zidovudine; Disodium Hydrogen Citrate; Oral Rehydration Solution; Efavirenz; Domperidone; Omeprazole; Lamivudine + Zidovudine; Tenofovir Disoproxil Fumarate
Possible Viramune side effects in male
Reported by a physician from India on 2012-03-16
Patient: male, weighing 49.5 kg (108.9 pounds)
Reactions: Pancytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Zidovudine
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-05
End date: 2012-02-28
Viramune
Dosage: 400 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-06
End date: 2012-02-28
Other drugs received by patient: Norfloxacin; Domperidone; Oral Rehydration Solution; Disodium Hydrogen Citrate; Omeprazole; Lamivudine + Zidovudine
|